Trial lecture and disputation October 27-28th
Kristine Gulliksrud
Siv. ing. Kristine Gulliksrud from Einar Rofstad's group at the Department of Radiation Biology at the Institute for Cancer Research will give her trial lectures on Thursday October 27th. The lecture over the subject of her own choice - "Assessment of tumor pH by magnetic resonance spectroscopy and imaging" starts at 14:15. The given subject is "Therapeutic approaches for dealing with the hypoxia problem", and this lecture begins at 15:15. Both trial lectures take place in the Auditorium in the Research Therapy Building at the OUS-Radiumhospitalet, Montebello. She will defend her PhD thesis - entitled "DCE-MRI in assessment of the microenvironment and aggressiveness of human tumor xenografts" the following day, on Friday October 28th at 10:15. The disputation takes place in the "Lille Fysiske auditorium, Fysikkbygningen" at the University of Oslo.
From major journals, first or last author from the Institute for Cancer Research
Lund-Andersen C, Torgunrud A, Kanduri C, Dagenborg VJ, Frøysnes IS, Larsen MM, Davidson B, Larsen SG, Flatmark K(2024) Novel drug resistance mechanisms and drug targets in BRAF-mutated peritoneal metastasis from colorectal cancer J Transl Med, 22(1), 646 DOI 10.1186/s12967-024-05467-2, PubMed 38982444
Hammer Q, Perica K, Mbofung RM, van Ooijen H, Martin KE, Momayyezi P, Varady E, Pan Y, Jelcic M, Groff B, Abujarour R, Krokeide SZ, Lee T, Williams A, Goodridge JP, Valamehr B, Önfelt B, Sadelain M, Malmberg KJ(2024) Genetic ablation of adhesion ligands mitigates rejection of allogeneic cellular immunotherapies Cell Stem Cell(in press) DOI 10.1016/j.stem.2024.06.011, PubMed 38981470
Andresen NK, Røssevold AH, Borgen E, Schirmer CB, Gilje B, Garred Ø, Lømo J, Stensland M, Nordgård O, Falk RS, Mathiesen RR, Russnes HG, Kyte JA, Naume B(2024) Circulating tumor cells in metastatic breast cancer patients treated with immune checkpoint inhibitors - a biomarker analysis of the ALICE and ICON trials Mol Oncol(in press) DOI 10.1002/1878-0261.13675, PubMed 38978352
Lê Quý K, Chernigovskaya M, Stensland M, Singh S, Leem J, Revale S, Yadin DA, Nice FL, Povall C, Minns DH, Galson JD, Nyman TA, Snapkow I, Greiff V(2024) Benchmarking and integrating human B-cell receptor genomic and antibody proteomic profiling NPJ Syst Biol Appl, 10(1), 73 DOI 10.1038/s41540-024-00402-z, PubMed 38997321
Lund-Andersen C, Torgunrud A, Kanduri C, Dagenborg VJ, Frøysnes IS, Larsen MM, Davidson B, Larsen SG, Flatmark K(2024) Novel drug resistance mechanisms and drug targets in BRAF-mutated peritoneal metastasis from colorectal cancer J Transl Med, 22(1), 646 DOI 10.1186/s12967-024-05467-2, PubMed 38982444
Andresen NK, Røssevold AH, Borgen E, Schirmer CB, Gilje B, Garred Ø, Lømo J, Stensland M, Nordgård O, Falk RS, Mathiesen RR, Russnes HG, Kyte JA, Naume B(2024) Circulating tumor cells in metastatic breast cancer patients treated with immune checkpoint inhibitors - a biomarker analysis of the ALICE and ICON trials Mol Oncol(in press) DOI 10.1002/1878-0261.13675, PubMed 38978352